Regional chemotherapy in locally advanced gastric cancer

Abstract

During 2008-2011 32 patients with locally advanced and metastatic gastric cancer passed 154 procedures of interventional radiology. Tumors of gastroesophageal junction were revealed in 7 patients, tumors of the fundus — in 15 patients, tumors of the pylorus — in 10 patients. At the time of treatment and hospitalization complicated course was observed in 14 patients. Upon initial treatment 25 patients (78%) manifested metastatic lesions in the liver. As an independent type of treatment interventional radiology was carried out in 20 patients. The combined treatment (surgery + intraarterial regional chemotherapy) was performed in 12 patients. 19 patients underwent chemoembolisation of the tumor (56 procedures in total). All patients had repeated courses of intraarterial regional chemoinfusion at intervals of 4-6 weeks (98 procedures in total). Surgical treatment was performed in terms of 7-16 days after the last course of neoadjuvant regional chemotherapy. A decrease of tumor size by 15% -35% (26% in average) was registered in all patients; a decrease in accumulation of radiopharmaceutical in tumors of the stomach was 18% -27% (20% in average). The results of the application of intraarterial regional chemotherapy (chemoembolisation tumors of the stomach and regional chemoinfusion) demonstrated the possibility of effective influence both on the primary tumor, and on the stages of lymph node metastasis. Also the use of regional neoadjuvant chemotherapy did not complicate the course of the postoperative period even in the group of patients who underwent extensive combined surgical intervention.
https://doi.org/10.37469/0507-3758-2012-58-6-762-767
PDF (Русский)

References

Аксель Е.М., Горбачева И.А. Злокачественные новообразованияв Москвеи Санкт -Петербурге // Вестн. РОНЦ им. Н.Н. Блохина РАМН. 2008. Т. 199, № 2 (прил. 1). С. 120 -134.

Арыбжанов Д.Т. Неоадъювантная регионарная химиотерапия при раке желудка // Вестник хирургии Казахстана. 2009. № 1. С. 23-26

Гранов A.M., Таразов П.Г., Гранов Д.А. Лечение первичногои метастатического рака печени // Анналы хирургич. гепатол. 1996. Т.1, № 1. С. 30-37.

Павловский А.В Масляная химиоэмболизация артерий поджелудочной железы при местнораспространенном раке // Практ. Онкол. 2004. Т. 5, № 2. С. 108-113.

Щепотин И.Б. Современные подходык профилактике, диагностикеи лечению рака желудка // Онкология. — 2002. — № 2. — С. 151-154.

Янкин А.В. Современная хирургия рака желудка // Практ. онкол. — 2009. Т.10, № 1. С. 12-19.

Bamias A., Karina M., Papakostas P. et al. A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer // Cancer Chemother. Pharmacol. 2010. Vol. 5. P. 1009-1021.

Biffi R., Fazio N., Luca F. et al. Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer // World J. Gastroenterol. 2010. Vol. 21, № 16(7). P. 868-874.

Blot W., Devesa S., Knellur R., Fraumeni J. Rising incidence of adenocarcinoma of the esophagus and gastric cardia // JAMA. 1999. Vol. 265. P. 1287-1291.

Cai J., Ikeguchi M., Maeta M., Kaibara N. Micrometastases in lymph nodes and microinvasion of the muskularis propria in primary lesions of submucosal gastric cancer // Surgery. 2000. Vol. 127. P. 32-39.

Gotoda T., Yanagisawa A., Sasako M. et al. Incidence of lymph node metastasis from early gastric cancer: estimation with large number of cases at to large centers // Gastric Cancer. 2000. N 3. P. 219-225.

Harrison L., Choe J., Goldstein M. et al. Prognostic significance immunohistochemical micrometastasis in node negative gastric cancer patients // J. Surg. Oncol. 2000. Vol. 73. P. 153-157.

Japannese Gastric Cancer Association. Japanese classification of gastric carcinoma -2nd England edition. Gastric Cancer, 1998. P. 110-124.

Karpeh M.S., Kelsen D.P., Tepper J.E. Cancer of the stomach In Cancer: Principles and Practice of oncology, 6th edition. New-York: Lippincott Williams and Wilkins. 2001. P. 1092-1125.

Kim D., Joo J., Ryu S. et al. Factors related to lymph node metastasis and surgical strategy used to treat early gastric carcinoma // World J. Gastroenterol. 2004. № 10. P. 737-740.

Kim J., Lee J., Han B. et al. Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer. // Cancer Chemother. Pharmacol. 2011. Vol. 68(1). P. 177-184.

Nakajo A., Natsugoe S., Ishigami S. et al. Detection and prediction of micrometastasis in the lymph nodes patients with pN0 gastric cancer // Ann. Surg. Oncol. 2001. Vol. 8. P. 158-162.

Nishiyama M., Wad S. Docetaxel: its role in current and future treatments for advanced gastric cancer // Gastric Cancer. 2009. № 12. P. 132-141.

Parkin D., Pisani P., Ferley J. et al. Global cancer statistics // Cancer J. Clin. 1999. Vol. 49. P. 33-64.

Takekoshi T., Baba Y., Ota H. et al. Endoscopic resection of early gastric carcinoma: results of retrospective analysis of 308 cases // Endoscopy. 1994. Vol. 26. P. 352-364.

All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...